Get started
Author

Rahul Vithalrao Parghane

Clinical utility of 177 Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity
2019 · Rahul V. Parghane, Chinna Naik, et al. · Head & Neck · 76
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
2020 · Sandip Basu, Rahul V. Parghane, et al. · Seminars in Nuclear Medicine · 66
Dual–time point 18 F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations
2017 · Rahul V. Parghane, Sandip Basu · Seminars in Nuclear Medicine · 65
Therapeutic efficacy, prognostic variables and clinical outcome of 177Lu-PSMA-617 PRLT in progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason score in such cohort
2019 · Sonam Suman, Rahul V. Parghane, et al. · British Journal of Radiology · 64
Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
2017 · Rahul V. Parghane, Sanjay Talole, et al. · Clinical Nuclear Medicine · 58
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant 177Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors
2021 · Rahul V. Parghane, Manish Bhandare, et al. · Journal of Nuclear Medicine · 57
PDF
Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease
2020 · Rahul V. Parghane, Vikas Ostwal, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 51
Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of 177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
2019 · Rahul V. Parghane, Sanjay Talole, et al. · World Journal of Nuclear Medicine · 36
PDF
Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting
2020 · Keerti Sitani, Rahul V Parghane, et al. · British Journal of Radiology · 34
PDF
Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability
2021 · Sonam Suman, Rahul V. Parghane, et al. · The Prostate · 25
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG Uptake
2020 · Vikas Ostwal, Sandip Basu, et al. · Neuroendocrinology · 24
Multiple brown tumors caused by a parathyroid adenoma mimicking metastatic bone disease from giant cell tumor
2015 · Rohit Phulsunga, Rahul Parghane, et al. · World Journal of Nuclear Medicine · 22
PDF
The efficacy, toxicity and survival of salvage retreatment PRRT with 177Lu-DOTATATE in patients with progressive NET following initial course of PRRT
2022 · Keerti Sitani, Rahul Parghane, et al. · British Journal of Radiology · 20
Role of 99mTc-Methylene Diphosphonate SPECT/CT in the Detection of Sacroiliitis in Patients with Spondyloarthropathy: Comparison with Clinical Markers and MRI
2017 · Rahul V. Parghane, Baljinder Singh, et al. · Journal of Nuclear Medicine Technology · 19
PDF
131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy
2020 · Rahul V. Parghane, Sanjay Talole, et al. · Annals of Nuclear Medicine · 16
68Ga DOTATATE PET/CT Imaging of a Solitary Fibrous Tumor of the Nasopharynx
2013 · Rahul Vithalrao Parghane, Kanhaiyalal Agrawal, et al. · Clinical Nuclear Medicine · 16
Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs
2020 · Sandip Basu, Rahul Parghane, et al. · World Journal of Nuclear Medicine · 15
PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects
2023 · Rahul V Parghane, Sandip Basu · Expert Review of Anticancer Therapy · 14
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (68Ga-PSMA and 18F-FDG): Potential Clinical Utility in Therapeutic Decision Making and Treatment Monitoring
2018 · Rahul Parghane, Sandip Basu · Journal of Nuclear Medicine Technology · 14
PDF
68Ga DOTATATE PET/CT in a Rare Coexistence of Pituitary Macroadenoma and Multiple Paragangliomas
2013 · Rahul Vithalrao Parghane, Kanhaiyalal Agrawal, et al. · Clinical Nuclear Medicine · 14
Role of fluorine-18 fluoride PET-CT scan in the assessment of unilateral condylar hyperplasia in faciomandibular asymmetry patients
2015 · Rais Ahmed, Satinder P. Singh, et al. · Nuclear Medicine Communications · 13
Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?
2019 · Sandip Basu, Rahul V. Parghane, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 12
PDF
PET/Computed Tomography in Treatment Response Assessment in Cancer
2019 · Rahul V. Parghane, Sandip Basu · PET Clinics · 12
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
2019 · Sandip Basu, Rahul V. Parghane, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 12
Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging
2026 · Andrew J. Einstein, Michelle C. Williams, et al. · JAMA · 11
Works count: 115
Citation count: 987
H-index: 16
I10-index: 28
Year
Topic
Type